首页 | 本学科首页   官方微博 | 高级检索  
     

新型冠状病毒疫苗相关的皮肤不良反应分析
引用本文:李阁,唐利利. 新型冠状病毒疫苗相关的皮肤不良反应分析[J]. 安徽医药, 2024, 28(8): 1693-1696
作者姓名:李阁  唐利利
作者单位:安徽医科大学附属巢湖医院皮肤科,安徽巢湖 238000;安徽医科大学第一附属医院皮肤科,安徽合肥 230020
基金项目:国家自然科学基金青年项目( 82103723)
摘    要:目的探讨巢湖市接种新型冠状病毒疫苗(新冠疫苗)后皮肤不良反应( CADRs)的发生情况。方法选取 2021年 1― 12月在安徽医科大学附属巢湖医院就诊的接种新冠疫苗后发生 CADRs病人 270例,并对其临床资料进行统计分析。结果 270例 CADRs病人中男 112例( 41.48%)女 158例( 58.52%)年龄范围为 4~90岁,年龄( 44.04±21.41)岁; CADRs发生时间主要集中在新冠疫苗接种后7d内(216例,8,0.0%); CADRs类型,主要包括荨麻疹( 85例, 31.48%)、接种部位局部红肿( 80例,29.63%)、非特异性皮疹( 78例, 28.89%)等;根据药物不良反应关联度评价,将皮疹表现类型分为很可能、可能及不明确三种,其中很可能的皮疹( 80例, 29.63%)、可能( 177例, 65.56%)、不明确( 13例, 4.81%)。根据引起皮肤不良反应的疫苗种类分为灭活疫苗( 142例, 52.60%)、重组疫苗( 128例, 47.40%);引起 CADRs的新冠疫苗接种剂次以第 1剂次居多( 178例, 65.92%)。结论接种新冠疫苗后发生的 CADRs中,以接种灭活疫苗多见,第 1剂次居多,多见于中年女性,临床症状以荨麻疹表现最常见。所有病人经有效治疗均痊愈,且不遗留后遗症。应正确看待疫苗接种引起的 CADRs,鼓励全员积极接种疫苗,共筑免疫屏障。

关 键 词:新型冠状病毒;新冠灭活疫苗;皮肤不良反应

Analysis of COVID-19 vaccination-related cutaneous adverse reactions
LI Ge,TANG Lili. Analysis of COVID-19 vaccination-related cutaneous adverse reactions[J]. Anhui Medical and Pharmaceutical Journal, 2024, 28(8): 1693-1696
Authors:LI Ge  TANG Lili
Affiliation:Department of Dermatology, Chaohu Hospital of Anhui Medical University, Chaohu, Anhui 238000, China; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China
Abstract:Objective To investigate the clinical manifestations and characteristics of cutaneous adverse reactions after receiving CO- VID-19 vaccines in Chaohu City, Anhui Province.Methods A total of 270 patients who had CADRs in Chaohu Hospital of Anhui Medical University after COVID-19 vaccination from January to December 2021 were selected for the study, whose general condition,clinical manifestations latency time, etc were analyzed.Results Among the 270 patients with CADRs , 112 (41.48%) were males and158 (58.52%) were females, with an average age of (44.04±21.41)years, ranging from 4 to 90 years old. CADRs mainly occurred within7 days after the COVID-19 vaccination (216 cases, 80.0%); The types of CADRs mainly included urticaria(85 cases, 31.48%), local red-ness and swelling at the vaccination site (80 cases, 29.63%), non-specific rash (78 cases, 28.89%), etc.Based on the correlation evalua-tion of the adverse drug reactions, clinical rash manifestations were classified into three types: probable, possible and unclear, of whichthe most probable rashes (80 cases, 29.63%); Possible (177 cases, 65.56%); Unclear (13 cases, 4.81%). According to the types of vac-cines that cause adverse skin reactions, they are divided into inactivated vaccine (142 cases, 52.60%) and recombinant vaccine (128cases, 47.40%); The first dose of COVID-19 vaccine was the most frequently used to cause CADRs (178 cases, 65.92%).Conclusions The skin adverse reactions caused by COVID-19 vaccines are more common in women. Urticarial rashes are the most frequently ob-served, and most cutaneous adverse reactions occurre within one week after vaccination. The skin adverse reactions caused by inactivat-ed vaccines are more common, and the first dose is the most frequent. After active and effective treatment, it can be cured without leav-ing sequelae. Therefore, dermatologists should correctly view the adverse reactions caused by vaccination, and encourage all employeesto actively vaccinate and build an immune barrier.
Keywords:COVID-19   COVID-19 vaccines   Cutaneous adverse reactions
点击此处可从《安徽医药》浏览原始摘要信息
点击此处可从《安徽医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号